Clinical evaluation of new biomarkers in diagnosis of valproate-induced renal tubular dysfunction.
Not Applicable
- Conditions
- Epilepsy
- Registration Number
- JPRN-UMIN000015787
- Lead Sponsor
- Department of Pediatrics, Kansai medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with renal diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -FABP(L-type fatty acid binding protein) could be a most sensitive biomarker for diagnosis of valproate-induced renal dysfunction.
- Secondary Outcome Measures
Name Time Method